Polyps and colorectal cancer in serrated polyposis syndrome: contribution of the classical adenoma-carcinoma and serrated neoplasia pathways.

David E F W M van ToledoJoep E G IJspeertHannah BoersmaAlex R MuslerArne G C BleijenbergEvelien DekkerCarel J M van Noesel

Published in: Clinical and translational gastroenterology (2023)

Our study indicates that in SPS patients the ratio of sCRCs:aCRCs on average is fifty:fifty. This elevated sCRC:aCRC ratio in SPS patients, as compared to non-SPS patients, correlates well with the differences in the ratios of the numbers of sessile serrated lesions and conventional adenomas in SPS and non-SPS patients respectively.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes